108 Episodes

  1. New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants

    Published: 4/3/2025
  2. Impact of NIH cuts on neurology research, response to ACP’s guideline on migraine, an updated position on seizures, driver licensure, and medical reporting

    Published: 3/20/2025
  3. Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists

    Published: 3/6/2025
  4. IVF and MS relapse, community-based neurologists doing clinical research, and the loneliness protein implicated in brain function.

    Published: 2/20/2025
  5. Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

    Published: 2/6/2025
  6. Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024.

    Published: 1/16/2025
  7. Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players.

    Published: 1/2/2025
  8. Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty

    Published: 12/19/2024
  9. 3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration

    Published: 12/5/2024
  10. Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s

    Published: 11/21/2024
  11. Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression

    Published: 11/7/2024
  12. Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder

    Published: 10/17/2024
  13. Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke

    Published: 10/3/2024
  14. Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s

    Published: 9/19/2024
  15. Alzheimer’s diagnosis criteria, AI and Parkinson’s severity, neurotoxicity of racism

    Published: 9/5/2024
  16. Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice

    Published: 8/15/2024
  17. Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer

    Published: 7/31/2024
  18. Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab

    Published: 7/18/2024
  19. Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology

    Published: 7/4/2024
  20. When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.

    Published: 6/20/2024

1 / 6

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.